SEC Filing Summary: Lunai Bioworks Inc. (Formerly Renovaro Inc.)
Business Context and Reporting Period
This Form 8-K Current Report, dated August 26, 2025, pertains to Renovaro Inc., which has officially changed its corporate name to Lunai Bioworks Inc. The name change became effective on August 20, 2025, following the filing of a Certificate of Amendment with the Delaware Secretary of State on August 18, 2025. The company is headquartered in Los Angeles, California, and its common stock trades on The Nasdaq Stock Market LLC under the ticker symbol RENB.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate name change and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name: Changed from "Renovaro Inc." to "Lunai Bioworks Inc."
- Stock Identification: While the ticker symbol remains RENB, the CUSIP number for the common stock will be changed as a result of the name change.
- Legal Status: The amendment to the Restated Certificate of Incorporation was filed and became effective in August 2025.
Guidance, Outlook, and Risks
Management commentary within the filing includes forward-looking statements regarding the Company's plans to hold its annual meeting and regain compliance with Nasdaq listing standards. The filing explicitly cautions that actual results may differ materially from these statements due to risks and uncertainties beyond the Company's control.
Key Facts for Investor Verification
- Verify the new CUSIP number for RENB shares following the name change.
- Monitor the company's progress in regaining compliance with Nasdaq listing standards.
- Confirm the date and details of the upcoming annual meeting referenced in forward-looking statements.
- Review the Certificate of Amendment (Exhibit 3.1) for any additional bylaw changes not summarized in the main text.